文献速递肿瘤 PET/CT

前列腺癌合并滤泡性淋巴瘤:PSMA与FDG PET/CT上的「翻转」表现

Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT Scans.
PubMed 文献 · Clin Nucl Med · 2019-01-01

本文报告一例75岁男性同时患转移性前列腺癌和进展性滤泡性淋巴瘤,通过FDG PET/CT和PSMA PET/CT两种分子影像检查区分两种病变。FDG PET/CT对前列腺癌作用有限,而PSMA PET/CT对前列腺癌的敏感性高于常规骨扫描和CT。两种PET/CT联合可无创地分别表征同时存在的恶性肿瘤,有助于优化治疗和随访。

要点

  • FDG与PSMA PET/CT在同时性肿瘤中可呈「翻转」表现,有助于鉴别病变来源。
  • PSMA PET/CT对前列腺癌的敏感性高于常规骨扫描和CT。
  • 联合分子影像可无创地表征同时性恶性肿瘤,辅助优化管理。

核心结论

  • FDG和PSMA PET/CT联合可无创地表征同时存在的恶性肿瘤,有助于优化治疗和随访。

研究设计与样本

  • 个案报告:一例75岁男性,同时患转移性前列腺癌和进展性滤泡性淋巴瘤。

主要发现

  • FDG PET/CT对前列腺癌作用有限,但在许多癌症中可提供准确分期。
  • PSMA PET/CT对前列腺癌的敏感性高于常规骨扫描和CT。
  • FDG与PSMA PET/CT在两种肿瘤中呈「翻转」表现,可区分病变来源。

临床怎么用

  • 对同时性恶性肿瘤患者,可联合FDG和PSMA PET/CT无创地表征各自病变,辅助优化治疗和随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We report a case of a 75-year-old man with concomitant metastatic prostate cancer and progressive follicular lymphoma and the utility of molecular imaging in differentiating these 2 conditions. F-FDG PET/CT can offer accurate staging in many cancers, although its role in prostate cancer is limited. The role of F-DCFPyL (PSMA) PET/CT in prostate cancer is evolving and has been demonstrated to have a higher sensitivity than conventional bone scan and CT scan. Together, FDG and PSMA PET/CT studies may offer a noninvasive approach to individually characterize concomitant malignancies, aiding optimization of management and follow-up.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Dhiantravan N, Hovey E, Bosco A, et al. Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT Scans. Clin Nucl Med. 2019. PMID: 31348079. doi:10.1097/RLU.0000000000002727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。